Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Immunotherapy for metastatic prostate cancer
Charles G. Drake
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunotherapy for metastatic prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Immunotherapy
100%
Prostatic Neoplasms
90%
Drug Therapy
44%
Docetaxel
42%
Survival
41%
Neoplasm Antibodies
25%
Active Immunotherapy
24%
Clinical Trials
24%
Asymptomatic Diseases
24%
Anti-Idiotypic Antibodies
15%
Therapeutics
12%
Quality of Life
12%